Form 4: Merit Medical Systems Director Lynne Ward Reports Stock Grant

Director Lynne Ward reported the acquisition of 2,431 restricted stock units (RSUs) in Merit Medical Systems, Inc.

Summary

• On May 16, 2024, Lynne Ward, a director of Merit Medical Systems Inc. (MMSI), acquired 2,431 shares of common stock through a grant of restricted stock units (RSUs).
• The RSUs were granted under the company's 2018 Long-Term Incentive Plan.
• These RSUs vest on May 16, 2025, contingent upon continued service to the issuer.
• Following the transaction, Ward directly owns 10,657 shares of Merit Medical Systems Inc.
• Ward also holds non-qualified stock options to purchase 5,433 shares of common stock at an exercise price of $34.46, which become exercisable in annual installments commencing August 28, 2020.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about stock transactions.

Positives

• The grant of RSUs aligns the director's interests with the long-term performance of the company.
• The vesting schedule encourages continued service to the company.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedule of the RSUs.

Industry Context

Form 4 filings are routine disclosures that provide transparency into the trading activities of company insiders, which can be informative for investors tracking management's sentiment and alignment with company performance.

Stakeholder Impact

• The transaction provides transparency to shareholders regarding the compensation and equity ownership of a company director.
• The vesting schedule of the RSUs incentivizes the director to remain with the company, which can benefit employees and other stakeholders.

Key Dates